EUVIMEDEUVIMED entdecken
Crossref

Interferon Regulatory Factor 8 Drives Autoimmune Neuroinflammation in Experimental Autoimmune Encephalomyelitis

Haruto Ojika, Kazuo Kunisawa, Moeka Tanabe, Yuki Kon, Koyo Yoshidomi, Yuta Naruoka, Moeka Ogawa, Mayu Kondo, Shoya Takeuchi, Aimi Sugiyama, Hiroyuki Tezuka, Hiroki Doi und 3 weitere

NeuroMolecular Medicine · 2026

DOI: 10.1007/s12017-026-08952-7 ↗

Kurz gefasst

Fachartikel in der Zeitschrift NeuroMolecular Medicine, 2026. Verfasst von Haruto Ojika und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Regulatory Science for Evaluation & Development of Pharmaceuticals & Devices, Fujita Health University Graduate School of Medical Scien…. Hauptthemen laut MEDLINE: Encephalomyelitis, Autoimmune, Experimental, Interferon Regulatory Factors, Multiple Sclerosis, Nerve Tissue Proteins. Die Arbeit nennt 54 Literaturangaben. Gefördert von: Grants-in-Aid for Scientific Research from the Japan Society for the Promotion of Science, the Japan Science and Technology Agency (JST) FOREST Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Multiple sclerosis (MS) is an immune-mediated demyelinating disease of the central nervous system. The interferon regulatory factor (IRF) family comprises transcription factors that regulate immune responses; however, their roles in MS pathogenesis remain unclear. In this study, we investigated whether IRFs are involved in MS pathology using experimental autoimmune encephalomyelitis (EAE) model mice. Among the IRFs examined, IRF8 expression was significantly increased in the spinal cord of EAE model mice and predominantly localized to myeloid cells. Consistently, patients with MS exhibited significantly increased proportions of IRF8-positive myeloid cells in peripheral blood. Notably, IRF8 knockout mice exhibited complete resistance to EAE induction. The mRNA expression levels of neuroinflammatory mediators, including interleukin IL-1β, IL-6, tumor necrosis factor-α, IL-12b, and nitric oxide synthase 2, were significantly reduced in the spinal cord of IRF8 knockout mice. Collectively, these findings suggest that IRF8 is a critical regulator of autoimmune neuroinflammation, highlighting its potential as a therapeutic target for MS.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Encephalomyelitis, Autoimmune, ExperimentalInterferon Regulatory FactorsMultiple SclerosisNerve Tissue ProteinsAnimalsInterferon Regulatory Factor-8Mice, KnockoutSpinal CordMiceFemaleMice, Inbred C57BLHumansCytokinesMyeloid CellsRNA, MessengerNitric Oxide Synthase Type IIInflammation MediatorsMyelin-Oligodendrocyte Glycoprotein

Stichwörter der Autor:innen

Interferon regulatory factor 8Multiple sclerosisMyeloid cellsNeuroinflammation

Substanzen

Interferon Regulatory FactorsInterferon Regulatory Factor-8CytokinesRNA, MessengerNerve Tissue ProteinsNitric Oxide Synthase Type IIInflammation MediatorsMyelin-Oligodendrocyte Glycoprotein

Autor:innen und Institutionen

  • Department of Regulatory Science for Evaluation & Development of Pharmaceuticals & Devices, Fujita Health University Graduate School of Medical Science, Toyoake, Aichi, 470-1192, Japan.
  • Department of Regulatory Science for Evaluation & Development of Pharmaceuticals & Devices, Fujita Health University Graduate School of Medical Science, Toyoake, Aichi, 470-1192, Japan. kunisawa@fujita-hu.ac.jp.
  • International Center for Brain Science (ICBS), Fujita Health University, Toyoake, Aichi, Japan. kunisawa@fujita-hu.ac.jp.
  • Japanese Drug Organization of Appropriate Use and Research, Nagoya, Aichi, Japan. kunisawa@fujita-hu.ac.jp.
  • Laboratory of Health and Medical Science Innovation, Fujita Health University Graduate School of Health Science, Toyoake, Aichi, Japan.
  • Department of Cellular Function Analysis, Research Promotion Headquarters, Fujita Health University, Toyoake, Aichi, Japan.

Förderung

  • Grants-in-Aid for Scientific Research from the Japan Society for the Promotion of Science
  • the Japan Science and Technology Agency (JST) FOREST Program

Zitieren

APA

Ojika, H., Kunisawa, K., Tanabe, M., Kon, Y., Yoshidomi, K., Naruoka, Y., Ogawa, M., Kondo, M., Takeuchi, S., Sugiyama, A., Tezuka, H., Doi, H., Tana, Nabeshima, T., & Mouri, A. (2026). Interferon Regulatory Factor 8 Drives Autoimmune Neuroinflammation in Experimental Autoimmune Encephalomyelitis. NeuroMolecular Medicine. https://doi.org/10.1007/s12017-026-08952-7

Vancouver

Ojika H, Kunisawa K, Tanabe M, Kon Y, Yoshidomi K, Naruoka Y, et al. Interferon Regulatory Factor 8 Drives Autoimmune Neuroinflammation in Experimental Autoimmune Encephalomyelitis. NeuroMolecular Medicine. 2026. doi:10.1007/s12017-026-08952-7

BibTeX
@article{Ojika2026,
  author = {Ojika, Haruto and Kunisawa, Kazuo and Tanabe, Moeka and Kon, Yuki and Yoshidomi, Koyo and Naruoka, Yuta and Ogawa, Moeka and Kondo, Mayu and Takeuchi, Shoya and Sugiyama, Aimi and Tezuka, Hiroyuki and Doi, Hiroki and Tana and Nabeshima, Toshitaka and Mouri, Akihiro},
  title = {Interferon Regulatory Factor 8 Drives Autoimmune Neuroinflammation in Experimental Autoimmune Encephalomyelitis},
  journal = {NeuroMolecular Medicine},
  year = {2026},
  doi = {10.1007/s12017-026-08952-7}
}
Kostenlos starten →